GlassScriptPhysician profile
Christopher H Byrne
NPI 1649430315
$1,676.76
in general payments reported to CMS, 2019-2025
6 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.00 · 2021: $38.77 · 2023: $23.45 · 2024: $1,392 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,120 · Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,119.62 |
| Food and Beverage | $507.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,432.66 | 2024-2025 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $73.10 | 2024 | Endurant Iis |
| Becton, Dickinson and Company | $63.48 | 2025 | Arista |
| Penumbra, INC. | $49.77 | 2020-2021 | |
| Veryan Medical Incorporated | $34.30 | 2025 | Biomimics 3d Vascular Stent System |
| Abbott Laboratories | $23.45 | 2023 | Jeti Peripheral Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.